These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 14681687
1. Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation. Mateo-Lozano S, Tirado OM, Notario V. Oncogene; 2003 Dec 18; 22(58):9282-7. PubMed ID: 14681687 [Abstract] [Full Text] [Related]
2. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells. Wang M, Xie Y, Girnita L, Nilsson G, Dricu A, Wejde J, Larsson O. Exp Cell Res; 1999 Jan 10; 246(1):38-46. PubMed ID: 9882513 [Abstract] [Full Text] [Related]
3. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells. Girnita L, Girnita A, Wang M, Meis-Kindblom JM, Kindblom LG, Larsson O. Oncogene; 2000 Aug 31; 19(37):4298-301. PubMed ID: 10980604 [Abstract] [Full Text] [Related]
4. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma. Mateo-Lozano S, Gokhale PC, Soldatenkov VA, Dritschilo A, Tirado OM, Notario V. Clin Cancer Res; 2006 Nov 15; 12(22):6781-90. PubMed ID: 17121899 [Abstract] [Full Text] [Related]
5. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity. Tirado OM, Mateo-Lozano S, Notario V. Oncogene; 2005 May 05; 24(20):3348-57. PubMed ID: 15782132 [Abstract] [Full Text] [Related]
6. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ, Kim SJ. Nat Genet; 1999 Oct 05; 23(2):222-7. PubMed ID: 10508522 [Abstract] [Full Text] [Related]
7. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. Chansky HA, Barahmand-Pour F, Mei Q, Kahn-Farooqi W, Zielinska-Kwiatkowska A, Blackburn M, Chansky K, Conrad EU, Bruckner JD, Greenlee TK, Yang L. J Orthop Res; 2004 Jul 05; 22(4):910-7. PubMed ID: 15183454 [Abstract] [Full Text] [Related]
8. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity. Myatt SS, Burchill SA. Oncogene; 2008 Feb 07; 27(7):985-96. PubMed ID: 17700534 [Abstract] [Full Text] [Related]
9. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance. Luo W, Gangwal K, Sankar S, Boucher KM, Thomas D, Lessnick SL. Oncogene; 2009 Nov 19; 28(46):4126-32. PubMed ID: 19718047 [Abstract] [Full Text] [Related]
10. Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1. Dohjima T, Ohno T, Banno Y, Nozawa Y, Wen-yi Y, Shimizu K. Br J Cancer; 2000 Jan 19; 82(1):16-9. PubMed ID: 10638960 [Abstract] [Full Text] [Related]
11. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Kovar H, Aryee DN, Jug G, Henöckl C, Schemper M, Delattre O, Thomas G, Gadner H. Cell Growth Differ; 1996 Apr 19; 7(4):429-37. PubMed ID: 9052984 [Abstract] [Full Text] [Related]
12. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL. Cancer Res; 2005 Oct 01; 65(19):8698-705. PubMed ID: 16204038 [Abstract] [Full Text] [Related]
13. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES. Oncogene; 1997 Mar 20; 14(11):1259-68. PubMed ID: 9178886 [Abstract] [Full Text] [Related]
14. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines. Rorie CJ, Weissman BE. Cancer Res; 2004 Oct 15; 64(20):7288-95. PubMed ID: 15492248 [Abstract] [Full Text] [Related]
15. EWS-FLI1 causes neuroepithelial defects and abrogates emigration of neural crest stem cells. Coles EG, Lawlor ER, Bronner-Fraser M. Stem Cells; 2008 Sep 15; 26(9):2237-44. PubMed ID: 18556509 [Abstract] [Full Text] [Related]
16. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. García-Aragoncillo E, Carrillo J, Lalli E, Agra N, Gómez-López G, Pestaña A, Alonso J. Oncogene; 2008 Oct 09; 27(46):6034-43. PubMed ID: 18591936 [Abstract] [Full Text] [Related]
17. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Dauphinot L, De Oliveira C, Melot T, Sevenet N, Thomas V, Weissman BE, Delattre O. Oncogene; 2001 May 31; 20(25):3258-65. PubMed ID: 11423975 [Abstract] [Full Text] [Related]
18. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Hosoi H, Dilling MB, Shikata T, Liu LN, Shu L, Ashmun RA, Germain GS, Abraham RT, Houghton PJ. Cancer Res; 1999 Feb 15; 59(4):886-94. PubMed ID: 10029080 [Abstract] [Full Text] [Related]
19. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. Fukuma M, Okita H, Hata J, Umezawa A. Oncogene; 2003 Jan 09; 22(1):1-9. PubMed ID: 12527902 [Abstract] [Full Text] [Related]
20. Context matters: the hen or egg problem in Ewing's sarcoma. Kovar H. Semin Cancer Biol; 2005 Jun 09; 15(3):189-96. PubMed ID: 15826833 [Abstract] [Full Text] [Related] Page: [Next] [New Search]